Russian Federation

Last Updated 2 December 2022.

6 Vaccines Approved for Use in Russian Federation

• Vector State Research Center of Virology and Biotechnology
  Aurora-CoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  Approval Source: interfax.com

  Protein Subunit

• Vector State Research Center of Virology and Biotechnology
  EpiVacCorona

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  4 trials in 1 country

  Approval Source: cnbc.com

  Protein Subunit

• Gamaleya
  Gam-COVID-Vac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 0 countries

  Approval Source: aninews.in

  Non Replicating Viral Vector

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 26 countries

  7 trials in 3 countries

  Approval Source: rdif.ru

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 74 countries

  25 trials in 8 countries

  Approval Source: theguardian.com

  Non Replicating Viral Vector

• Chumakov Center
  KoviVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 3 countries

  3 trials in 1 country

  Approval Source: grls.rosminzdrav.ru

  Inactivated

11 Vaccines in Clinical Trials in Russian Federation

• Vector State Research Center of Virology and Biotechnology
  EpiVacCorona

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  4 trials in 1 country

  Protein Subunit

• CanSino
  Convidecia

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 10 countries

  14 trials in 6 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 26 countries

  7 trials in 3 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 74 countries

  25 trials in 8 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Non Replicating Viral Vector

• Human Stem Cell Institute Russia
  Betuvax-CoV-2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• St. Petersburg Research Institute of Vaccines and Sera
  Recombinant subunit vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• Vector State Research Center of Virology and Biotechnology
  Aurora-CoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  Protein Subunit

• Biocad
  BCD-250

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Non Replicating Viral Vector

• Institute of Vaccines and Medical Biologicals
  COVIVAC

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  4 trials in 2 countries

  Non Replicating Viral Vector

• Chumakov Center
  KoviVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 3 countries

  3 trials in 1 country

  Inactivated